Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.
暂无分享，去创建一个
A. Hottinger | S. Momjian | P. Walker | A. Lobrinus | M. Vargas | A. Patrikidou | D. Merkler | P. Dietrich | M. Kreutzfeldt | V. Dutoit | M. Allard | E. Marinari | D. Migliorini | Avinash Koka | V. Widmer | Géraldine Philippin | N. Blazek | F. Corlazzoli | R. Gustave | Nicole Grandjean Hallez | J. Wasem